List of Tables
Table 1. Global Peptic Ulcer Disease Medication Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Peptic Ulcer Disease Medication Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Peptic Ulcer Disease Medication Market Competitive Situation by Manufacturers in 2024
Table 4. Global Peptic Ulcer Disease Medication Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Peptic Ulcer Disease Medication Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Peptic Ulcer Disease Medication Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Peptic Ulcer Disease Medication Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Peptic Ulcer Disease Medication Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Peptic Ulcer Disease Medication, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peptic Ulcer Disease Medication, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peptic Ulcer Disease Medication, Product Type & Application
Table 12. Global Key Manufacturers of Peptic Ulcer Disease Medication, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peptic Ulcer Disease Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptic Ulcer Disease Medication as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peptic Ulcer Disease Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Peptic Ulcer Disease Medication Sales by Region (2020-2025) & (K Units)
Table 18. Global Peptic Ulcer Disease Medication Sales Market Share by Region (2020-2025)
Table 19. Global Peptic Ulcer Disease Medication Sales by Region (2026-2031) & (K Units)
Table 20. Global Peptic Ulcer Disease Medication Sales Market Share by Region (2026-2031)
Table 21. Global Peptic Ulcer Disease Medication Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Peptic Ulcer Disease Medication Revenue Market Share by Region (2020-2025)
Table 23. Global Peptic Ulcer Disease Medication Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Peptic Ulcer Disease Medication Revenue Market Share by Region (2026-2031)
Table 25. North America Peptic Ulcer Disease Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Peptic Ulcer Disease Medication Sales by Country (2020-2025) & (K Units)
Table 27. North America Peptic Ulcer Disease Medication Sales by Country (2026-2031) & (K Units)
Table 28. North America Peptic Ulcer Disease Medication Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Peptic Ulcer Disease Medication Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Peptic Ulcer Disease Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Peptic Ulcer Disease Medication Sales by Country (2020-2025) & (K Units)
Table 32. Europe Peptic Ulcer Disease Medication Sales by Country (2026-2031) & (K Units)
Table 33. Europe Peptic Ulcer Disease Medication Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Peptic Ulcer Disease Medication Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Peptic Ulcer Disease Medication Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Peptic Ulcer Disease Medication Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Peptic Ulcer Disease Medication Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Peptic Ulcer Disease Medication Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Peptic Ulcer Disease Medication Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptic Ulcer Disease Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Peptic Ulcer Disease Medication Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Peptic Ulcer Disease Medication Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Peptic Ulcer Disease Medication Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Peptic Ulcer Disease Medication Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Peptic Ulcer Disease Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Peptic Ulcer Disease Medication Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Peptic Ulcer Disease Medication Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Peptic Ulcer Disease Medication Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Peptic Ulcer Disease Medication Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Peptic Ulcer Disease Medication Sales (K Units) by Type (2020-2025)
Table 51. Global Peptic Ulcer Disease Medication Sales (K Units) by Type (2026-2031)
Table 52. Global Peptic Ulcer Disease Medication Sales Market Share by Type (2020-2025)
Table 53. Global Peptic Ulcer Disease Medication Sales Market Share by Type (2026-2031)
Table 54. Global Peptic Ulcer Disease Medication Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Peptic Ulcer Disease Medication Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Peptic Ulcer Disease Medication Revenue Market Share by Type (2020-2025)
Table 57. Global Peptic Ulcer Disease Medication Revenue Market Share by Type (2026-2031)
Table 58. Global Peptic Ulcer Disease Medication Price (US$/Unit) by Type (2020-2025)
Table 59. Global Peptic Ulcer Disease Medication Price (US$/Unit) by Type (2026-2031)
Table 60. Global Peptic Ulcer Disease Medication Sales (K Units) by Application (2020-2025)
Table 61. Global Peptic Ulcer Disease Medication Sales (K Units) by Application (2026-2031)
Table 62. Global Peptic Ulcer Disease Medication Sales Market Share by Application (2020-2025)
Table 63. Global Peptic Ulcer Disease Medication Sales Market Share by Application (2026-2031)
Table 64. Global Peptic Ulcer Disease Medication Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Peptic Ulcer Disease Medication Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Peptic Ulcer Disease Medication Revenue Market Share by Application (2020-2025)
Table 67. Global Peptic Ulcer Disease Medication Revenue Market Share by Application (2026-2031)
Table 68. Global Peptic Ulcer Disease Medication Price (US$/Unit) by Application (2020-2025)
Table 69. Global Peptic Ulcer Disease Medication Price (US$/Unit) by Application (2026-2031)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Bayer Peptic Ulcer Disease Medication Product
Table 74. Bayer Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Peptic Ulcer Disease Medication Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Teva Peptic Ulcer Disease Medication Product
Table 84. Teva Recent Developments/Updates
Table 85. Takeda Company Information
Table 86. Takeda Description and Business Overview
Table 87. Takeda Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Takeda Peptic Ulcer Disease Medication Product
Table 89. Takeda Recent Developments/Updates
Table 90. AstraZeneca Company Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. AstraZeneca Peptic Ulcer Disease Medication Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Sun Pharma Company Information
Table 96. Sun Pharma Description and Business Overview
Table 97. Sun Pharma Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Sun Pharma Peptic Ulcer Disease Medication Product
Table 99. Sun Pharma Recent Developments/Updates
Table 100. Mylan Company Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Mylan Peptic Ulcer Disease Medication Product
Table 104. Mylan Recent Developments/Updates
Table 105. Eisai Co. Company Information
Table 106. Eisai Co. Description and Business Overview
Table 107. Eisai Co. Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Eisai Co. Peptic Ulcer Disease Medication Product
Table 109. Eisai Co. Recent Developments/Updates
Table 110. CTTQ Company Information
Table 111. CTTQ Description and Business Overview
Table 112. CTTQ Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. CTTQ Peptic Ulcer Disease Medication Product
Table 114. CTTQ Recent Developments/Updates
Table 115. Livzon Pharmaceutical Company Information
Table 116. Livzon Pharmaceutical Description and Business Overview
Table 117. Livzon Pharmaceutical Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Livzon Pharmaceutical Peptic Ulcer Disease Medication Product
Table 119. Livzon Pharmaceutical Recent Developments/Updates
Table 120. Eastchina Pharma Company Information
Table 121. Eastchina Pharma Description and Business Overview
Table 122. Eastchina Pharma Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Eastchina Pharma Peptic Ulcer Disease Medication Product
Table 124. Eastchina Pharma Recent Developments/Updates
Table 125. Luoxin Pharma Company Information
Table 126. Luoxin Pharma Description and Business Overview
Table 127. Luoxin Pharma Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Luoxin Pharma Peptic Ulcer Disease Medication Product
Table 129. Luoxin Pharma Recent Developments/Updates
Table 130. Jumpcan Pharmaceutical Company Information
Table 131. Jumpcan Pharmaceutical Description and Business Overview
Table 132. Jumpcan Pharmaceutical Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Jumpcan Pharmaceutical Peptic Ulcer Disease Medication Product
Table 134. Jumpcan Pharmaceutical Recent Developments/Updates
Table 135. AOSAIKANG Pharma Company Information
Table 136. AOSAIKANG Pharma Description and Business Overview
Table 137. AOSAIKANG Pharma Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. AOSAIKANG Pharma Peptic Ulcer Disease Medication Product
Table 139. AOSAIKANG Pharma Recent Developments/Updates
Table 140. Jiangsu Aosaikang Pharmaceutical Company Information
Table 141. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 142. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Disease Medication Product
Table 144. Jiangsu Aosaikang Pharmaceutical Recent Developments/Updates
Table 145. Youcare Pharmaceutical Company Information
Table 146. Youcare Pharmaceutical Description and Business Overview
Table 147. Youcare Pharmaceutical Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Youcare Pharmaceutical Peptic Ulcer Disease Medication Product
Table 149. Youcare Pharmaceutical Recent Developments/Updates
Table 150. Zhejiang Conba Pharmaceutical Company Information
Table 151. Zhejiang Conba Pharmaceutical Description and Business Overview
Table 152. Zhejiang Conba Pharmaceutical Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Zhejiang Conba Pharmaceutical Peptic Ulcer Disease Medication Product
Table 154. Zhejiang Conba Pharmaceutical Recent Developments/Updates
Table 155. Chongqing Lummy Pharmaceutical Company Information
Table 156. Chongqing Lummy Pharmaceutical Description and Business Overview
Table 157. Chongqing Lummy Pharmaceutical Peptic Ulcer Disease Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Chongqing Lummy Pharmaceutical Peptic Ulcer Disease Medication Product
Table 159. Chongqing Lummy Pharmaceutical Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Peptic Ulcer Disease Medication Distributors List
Table 163. Peptic Ulcer Disease Medication Customers List
Table 164. Peptic Ulcer Disease Medication Market Trends
Table 165. Peptic Ulcer Disease Medication Market Drivers
Table 166. Peptic Ulcer Disease Medication Market Challenges
Table 167. Peptic Ulcer Disease Medication Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Peptic Ulcer Disease Medication
Figure 2. Global Peptic Ulcer Disease Medication Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptic Ulcer Disease Medication Market Share by Type: 2024 & 2031
Figure 4. Acid-suppressing Drugs (Proton Pump Inhibitors, H2 Receptor Antagonists, etc.) Product Picture
Figure 5. Mucosal Protective Agents (Bismuth, Sucralfate, etc.) Product Picture
Figure 6. Antacids (Aluminum Hydroxide, Magnesium Hydroxide, etc.) Product Picture
Figure 7. Anti-Helicobacter Pylori Drugs Product Picture
Figure 8. Others Product Picture
Figure 9. Global Peptic Ulcer Disease Medication Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Peptic Ulcer Disease Medication Market Share by Application: 2024 & 2031
Figure 11. Hospitals and Clinics
Figure 12. Pharmacy
Figure 13. Global Peptic Ulcer Disease Medication Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Peptic Ulcer Disease Medication Market Size (2020-2031) & (US$ Million)
Figure 15. Global Peptic Ulcer Disease Medication Sales (2020-2031) & (K Units)
Figure 16. Global Peptic Ulcer Disease Medication Average Price (US$/Unit) & (2020-2031)
Figure 17. Peptic Ulcer Disease Medication Report Years Considered
Figure 18. Peptic Ulcer Disease Medication Sales Share by Manufacturers in 2024
Figure 19. Global Peptic Ulcer Disease Medication Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Peptic Ulcer Disease Medication Players: Market Share by Revenue in Peptic Ulcer Disease Medication in 2024
Figure 21. Peptic Ulcer Disease Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Peptic Ulcer Disease Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Peptic Ulcer Disease Medication Sales Market Share by Country (2020-2031)
Figure 24. North America Peptic Ulcer Disease Medication Revenue Market Share by Country (2020-2031)
Figure 25. United States Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Peptic Ulcer Disease Medication Sales Market Share by Country (2020-2031)
Figure 28. Europe Peptic Ulcer Disease Medication Revenue Market Share by Country (2020-2031)
Figure 29. Germany Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Peptic Ulcer Disease Medication Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Peptic Ulcer Disease Medication Revenue Market Share by Region (2020-2031)
Figure 36. China Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Peptic Ulcer Disease Medication Sales Market Share by Country (2020-2031)
Figure 44. Latin America Peptic Ulcer Disease Medication Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Peptic Ulcer Disease Medication Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Peptic Ulcer Disease Medication Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Peptic Ulcer Disease Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Peptic Ulcer Disease Medication by Type (2020-2031)
Figure 55. Global Revenue Market Share of Peptic Ulcer Disease Medication by Type (2020-2031)
Figure 56. Global Peptic Ulcer Disease Medication Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Peptic Ulcer Disease Medication by Application (2020-2031)
Figure 58. Global Revenue Market Share of Peptic Ulcer Disease Medication by Application (2020-2031)
Figure 59. Global Peptic Ulcer Disease Medication Price (US$/Unit) by Application (2020-2031)
Figure 60. Peptic Ulcer Disease Medication Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
